ArticlePathogens (Basel, Switzerland)2025

Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis.

Marcelo M Jesus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.